India Keeps Door Ajar For Hydroxychloroquine Exports, Drug Makers Geared Up

Indian drug makers appear confident of meeting both domestic and global requirements for hydroxychloroquine sulphate after India relaxed export curbs on the product, subject to strict monitoring, against the backdrop of requests from global heads of government for supplies of the potential treatment for COVID-19.

Arch_Hands
India Relaxes Export Hold On Hydroxychloroquine, Paracetamol • Source: Shutterstock

Narendra Modi’s phone doesn’t seem to have stopped ringing over the past few days, with several heads of government reaching out to India's prime minister to discuss efforts to jointly tackle the spread of COVID-19 that has ravaged countries large and small.

But amid these conversations, there appears to have been one common thread – requests to ensure that India doesn’t completely...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from India

More from Focus On Asia